[HTML][HTML] Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy …

H Bahig, Y Yuan, ASR Mohamed, KK Brock… - Clinical and translational …, 2018 - Elsevier
Background Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy …

H Bahig, Y Yuan, ASR Mohamed, KK Brock, SP Ng… - 2018 - repository.icr.ac.uk
BACKGROUND: Current standard radiotherapy for oropharynx cancer (OPC) is associated
with high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

[PDF][PDF] Clinical and Translational Radiation Oncology

MRR Assessment - 2018 - researchgate.net
abstract Background: Current standard radiotherapy for oropharynx cancer (OPC) is
associated with high rates of severe toxicities, shown to adversely impact patients' quality of …

Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy (MR …

H Bahig, Y Yuan, ASR Mohamed, KK Brock, SP Ng… - 2018 - christie.openrepository.com
Background: Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy …

H Bahig, Y Yuan, ASR Mohamed… - Clinical and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

[HTML][HTML] Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with …

H Bahig, Y Yuan, ASR Mohamed… - Clinical and …, 2018 - ncbi.nlm.nih.gov
abstract Background: Current standard radiotherapy for oropharynx cancer (OPC) is
associated with high rates of severe toxicities, shown to adversely impact patients' quality of …

[HTML][HTML] Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with …

H Bahig, Y Yuan, ASR Mohamed, KK Brock… - Clinical and …, 2018 - ctro.science
Background Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

[PDF][PDF] Clinical and Translational Radiation Oncology

MRR Assessment - 2018 - academia.edu
abstract Background: Current standard radiotherapy for oropharynx cancer (OPC) is
associated with high rates of severe toxicities, shown to adversely impact patients' quality of …

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy …

H Bahig, Y Yuan, ASR Mohamed… - Clinical and …, 2018 - mdanderson.elsevierpure.com
Background: Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy …

H Bahig, Y Yuan, ASR Mohamed, KK Brock… - Clinical and …, 2018 - europepmc.org
Background Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …